- Home
- GBAB vs ANGO Comparison
GBAB vs ANGO Comparison
Compare GBAB & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBAB
- ANGO
- Stock Information
- Founded
- GBAB 2010
- ANGO 1988
- Country
- GBAB United States
- ANGO United States
- Employees
- GBAB N/A
- ANGO N/A
- Industry
- GBAB Investment Managers
- ANGO Medical/Dental Instruments
- Sector
- GBAB Finance
- ANGO Health Care
- Exchange
- GBAB Nasdaq
- ANGO Nasdaq
- Market Cap
- GBAB 394.5M
- ANGO 439.5M
- IPO Year
- GBAB N/A
- ANGO 2004
- Fundamental
- Price
- GBAB $14.71
- ANGO $10.02
- Analyst Decision
- GBAB
- ANGO Strong Buy
- Analyst Count
- GBAB 0
- ANGO 2
- Target Price
- GBAB N/A
- ANGO $14.00
- AVG Volume (30 Days)
- GBAB 69.4K
- ANGO 755.2K
- Earning Date
- GBAB 01-01-0001
- ANGO 07-15-2025
- Dividend Yield
- GBAB 9.18%
- ANGO N/A
- EPS Growth
- GBAB N/A
- ANGO N/A
- EPS
- GBAB N/A
- ANGO N/A
- Revenue
- GBAB N/A
- ANGO $283,320,000.00
- Revenue This Year
- GBAB N/A
- ANGO N/A
- Revenue Next Year
- GBAB N/A
- ANGO $6.35
- P/E Ratio
- GBAB N/A
- ANGO N/A
- Revenue Growth
- GBAB N/A
- ANGO N/A
- 52 Week Low
- GBAB $14.22
- ANGO $5.47
- 52 Week High
- GBAB $17.44
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- GBAB 40.48
- ANGO 46.10
- Support Level
- GBAB $14.48
- ANGO $9.69
- Resistance Level
- GBAB $14.80
- ANGO $10.95
- Average True Range (ATR)
- GBAB 0.16
- ANGO 0.56
- MACD
- GBAB -0.01
- ANGO -0.11
- Stochastic Oscillator
- GBAB 23.92
- ANGO 24.00
About GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest
Guggenheim Taxable Municipal Managed Duration Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.